CN116590225B - Application of phosphatidylcholine in preparation of preparation for promoting pig FAPs cell differentiation polyester - Google Patents
Application of phosphatidylcholine in preparation of preparation for promoting pig FAPs cell differentiation polyester Download PDFInfo
- Publication number
- CN116590225B CN116590225B CN202310530141.3A CN202310530141A CN116590225B CN 116590225 B CN116590225 B CN 116590225B CN 202310530141 A CN202310530141 A CN 202310530141A CN 116590225 B CN116590225 B CN 116590225B
- Authority
- CN
- China
- Prior art keywords
- faps
- sodium alginate
- calcium chloride
- gelatin
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 title claims abstract description 31
- 229920000728 polyester Polymers 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 230000024245 cell differentiation Effects 0.000 title claims abstract description 11
- 230000001737 promoting effect Effects 0.000 title claims abstract description 9
- 238000004113 cell culture Methods 0.000 claims abstract description 11
- 235000013372 meat Nutrition 0.000 claims abstract description 10
- 239000004480 active ingredient Substances 0.000 claims abstract description 4
- 241000282898 Sus scrofa Species 0.000 claims description 27
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 24
- 239000008273 gelatin Substances 0.000 claims description 24
- 229920000159 gelatin Polymers 0.000 claims description 24
- 235000010413 sodium alginate Nutrition 0.000 claims description 24
- 239000000661 sodium alginate Substances 0.000 claims description 24
- 229940005550 sodium alginate Drugs 0.000 claims description 24
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 21
- 108010010803 Gelatin Proteins 0.000 claims description 20
- 235000019322 gelatine Nutrition 0.000 claims description 20
- 235000011852 gelatine desserts Nutrition 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 12
- 239000000499 gel Substances 0.000 claims description 10
- 230000009815 adipogenic differentiation Effects 0.000 claims description 8
- 239000006285 cell suspension Substances 0.000 claims description 8
- 239000001963 growth medium Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 238000004132 cross linking Methods 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 6
- 238000005119 centrifugation Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 102000004142 Trypsin Human genes 0.000 claims description 3
- 108090000631 Trypsin Proteins 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 230000029087 digestion Effects 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 239000012588 trypsin Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 230000001502 supplementing effect Effects 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 230000008021 deposition Effects 0.000 abstract description 9
- 238000007918 intramuscular administration Methods 0.000 abstract description 7
- 230000033228 biological regulation Effects 0.000 abstract description 6
- 150000002632 lipids Chemical class 0.000 abstract description 6
- 238000012216 screening Methods 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 47
- 230000004069 differentiation Effects 0.000 description 18
- 239000002609 medium Substances 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 10
- 241000282887 Suidae Species 0.000 description 8
- 230000014509 gene expression Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 230000006698 induction Effects 0.000 description 7
- VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 6
- 102100023915 Insulin Human genes 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 230000004136 fatty acid synthesis Effects 0.000 description 5
- 230000004927 fusion Effects 0.000 description 5
- 230000001228 trophic effect Effects 0.000 description 5
- 229930040373 Paraformaldehyde Natural products 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 229920002866 paraformaldehyde Polymers 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 230000002293 adipogenic effect Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 235000015277 pork Nutrition 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 210000000130 stem cell Anatomy 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940030275 epigallocatechin gallate Drugs 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 210000003668 pericyte Anatomy 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- JMGXWHJPYZENAF-UHFFFAOYSA-N 1-(4-butoxy-3-hydroxy-5,7-dimethoxy-2,2-dimethyl-3,4-dihydrochromen-6-yl)ethanone Chemical compound CCCCOC1C(O)C(C)(C)Oc2cc(OC)c(C(C)=O)c(OC)c12 JMGXWHJPYZENAF-UHFFFAOYSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 101100244177 Caenorhabditis elegans plin-1 gene Proteins 0.000 description 1
- 101150065105 Cidec gene Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102100030431 Fatty acid-binding protein, adipocyte Human genes 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 101001062864 Homo sapiens Fatty acid-binding protein, adipocyte Proteins 0.000 description 1
- 101001129132 Homo sapiens Perilipin-1 Proteins 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 101150023417 PPARG gene Proteins 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 102100031261 Perilipin-1 Human genes 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 239000006180 TBST buffer Substances 0.000 description 1
- 230000011759 adipose tissue development Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003352 fibrogenic effect Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000029712 muscle cell homeostasis Effects 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 230000009756 muscle regeneration Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000003170 nutritional factors Nutrition 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 229960004586 rosiglitazone Drugs 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000001646 side-population cell Anatomy 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000001057 smooth muscle myoblast Anatomy 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0653—Adipocytes; Adipose tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2513/00—3D culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
- C12N2533/74—Alginate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2535/00—Supports or coatings for cell culture characterised by topography
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses application of phosphatidylcholine in preparation of a preparation for promoting pig FAPs cell differentiation polyester, belonging to the fields of agriculture and food science. The preparation phosphatidylcholine capable of effectively promoting the cell differentiation and polyester of the pig FAPs is obtained by screening various lipid factors and plant active ingredients, and the action concentration of the phosphatidylcholine for promoting the cell differentiation and polyester of the pig FAPs is determined; meanwhile, the effect of the strain is further verified under the 3D culture condition, and a new strategy can be provided for efficient production of high-quality cell culture meat and deposition regulation of animal intramuscular fat.
Description
Technical Field
The invention belongs to the field of agriculture and food science, and particularly relates to application of phosphatidylcholine in preparation of a polyester preparation for promoting cell differentiation of pig FAPs.
Background
Fat deposition in skeletal muscle, especially intramuscular fat (Intramuscular Fat, IMF) deposition, is closely related to the meat quality formation of livestock and poultry, and the content of the fat deposition is closely related to the organoleptic and edible quality of pork, so that a plurality of indexes such as the flavor, juiciness, tenderness, color and the like of the pork are directly determined. In recent years, related research on the deposition mechanism of IMF and the regulation thereof has been greatly advanced at home and abroad, but the cell source of IMF and the targeting regulation strategy thereof need to be further researched. IMF cells were found to differentiate from a variety of stem and progenitor cells, including, for example, side group cells (Side population cells, SP cells), pericytes (Pericytes), multipotent mesenchymal stem cells (Mesenchymal stem cells, MSCs), myosatellite cells (Muscle satellite cells muscle, SCs), fibroadipogenic progenitor cells (fibrio/adipogenic progenitors, FAPs), and the like, wherein FAPs specifically express pdgfrα and Sca-1, are the primary sources of cells in human and mouse muscle regeneration. FAPs are capable of directional differentiation in the adipogenic and fibrogenic directions, leading to fat deposition and fibrosis in the muscle. Therefore, how to regulate the differentiation potential of FAPs is of great importance for maintaining muscle growth and homeostasis and regulating intramuscular fat deposition.
At present, research on FAPs differentiation regulation is mainly focused on human and mice, and although porcine FAPs cells are annotated by recent porcine muscle single cell sequencing papers, papers such as FAPs in vitro culture and differentiation regulation are not reported.
At present, the related research of the FAPs of pigs is in a starting stage, and a method for targeted regulation and control of the differentiated polyester and intramuscular fat deposition of the FAPs is lacking; seed cells produced by meat cultures are currently mainly used as muscle satellite cells, whereas the nutritional components of single cell-derived meat cultures are also greatly different from normal muscle tissue, mainly because muscle tissue contains a variety of cells.
Disclosure of Invention
According to the invention, the pig FAPs cells are separated by using an immunomagnetic bead separation technology, an in-vitro 2D/3D culture system and a fat-forming induction method of the FAPs cells are initially established, but a method for regulating fat-forming differentiation of the FAPs cells in a targeted manner through a nutrition strategy so as to regulate intramuscular fat deposition and improve pork quality is still lacking. The preparation which can effectively promote the differentiation of the FAPs cells of the pigs to polyester is obtained by screening various lipid factors and plant active ingredients.
The invention provides application of phosphatidylcholine in preparation of a preparation for promoting pig FAPs cell differentiation polyester.
Preferably, phosphatidylcholine alone is the active ingredient in the formulation.
More optionally, the preparation further comprises auxiliary materials.
The invention also provides a preparation method of the cell culture meat, which comprises the following steps:
(1) Preparation of sodium alginate/gelatin 3D gel ball
Sodium alginate-gelatin solution (sodium alginate/gelatin mixed sol) with concentration of 2% was obtained by dissolving 0.5 g sodium alginate and 0.5 g gelatin in 50mL distilled water. 1g of calcium chloride was dissolved in 50mL distilled water to obtain a calcium chloride solution having a concentration of 2%. Dropwise adding the sodium alginate/gelatin solution into the calcium chloride solution, and crosslinking for 5-15 min to obtain sodium alginate/gelatin 3D gel balls;
(2) Inoculating FAPs cells on sodium alginate and sodium alginate/gelatin 3D bracket
Adding a calcium chloride solution into a cell culture plate, and mixing a pig FAPs cell suspension with sodium alginate/gelatin mixed sol according to a volume ratio of 1: 1-3, dropwise adding the mixture into a calcium chloride solution, and crosslinking for 5-15 min to form gel balls; discarding the residual calcium chloride solution, supplementing the growth medium, and adding 5% CO at 37deg.C 2 Culturing in environment, performing adipogenic differentiation culture, and adding 1-100 μm PC during the adipogenic differentiation culture to obtain cell culture meat.
Preferably, in the step (1), sodium alginate solution, gelatin solution and calcium chloride solution are heated at 98 ℃ for 3 h respectively, ultraviolet irradiation is performed for 3 h sterilization, and the calcium chloride solution is filtered through a 0.22 μm filter membrane.
More preferably, the cells of porcine FAPs in step (2) are at 37℃with 5% CO 2 Culturing in an incubator until the cell confluence rate reaches 75-85%, and obtaining the cell suspension of the pig FAPs through trypsin digestion and centrifugation.
More preferably, the concentration of the cell suspension of porcine FAPs in step (2) is 1.5X10 5 cell/ml。
More preferably, the crosslinking time in the step (2) is 10min.
Compared with the prior art, the invention has the following beneficial effects:
the phosphatidylcholine can obviously promote the FAPs cells of pigs to differentiate and polyester, thereby improving the intramuscular fat content.
Drawings
FIG. 1 is a graph showing the effect of different trophic factors on the differentiation of polyester from porcine FAPs in example 1.
FIG. 2 is a graph showing the effect of PC on the differentiation of polyester from porcine FAPs (Nile red staining) in example 2.
FIG. 3 is a graph showing the effect of PC on expression of fatty acid synthesis-related genes of FAPs in swine in example 2.
FIG. 4 is a graph showing the effect of PC on expression of fatty acid synthesis-related proteins of FAPs in pigs in example 2.
FIG. 5 is a graph showing the effect of PC on polyester differentiation (Nile red staining) of swine FAPs under 3D culture conditions in example 3.
Detailed Description
Example 1 nutritional factor screening to promote the differentiation of porcine FAPs cells into polyester
1. Pig FAPs cell culture
Culture medium for subculture: dmem+15% fbs+1% diabody; changing the liquid once in two days, and washing twice with FBS before changing the liquid; and (5) passaging when the cell fusion rate reaches 85%.
And (3) passage: the medium was discarded, 2mL of PBS was added to wash the cells, PBS was discarded, 1.5. 1.5 mL pancreatin was added, digested for 3 min at 37 ℃,1 mL complete medium was added, after mixing, transferred to a centrifuge tube of 5mL, centrifuged at 1000 rpm for 4 min, after centrifugation the supernatant was discarded, resuspended in complete medium and inoculated into a culture plate for further culture.
2. Setting concentration gradient of nutrient factors
Each trophic factor was set to 4 concentration gradients: phosphatidylcholine (PC) is divided into 0, 1 μm, 10 μm, 100 μm; betaines (Bet) are classified as 0, 0.1 mM, 0.2 mM, 0.4 mM; epigallocatechin gallate (EGCG) is divided into 0, 0.2 μM, 2 μM, and 20 μM; phosphatidylserine (PS) is classified into 0, 1 μm, 10 μm, 100 μm; ornithine (Orithine) is classified into 0, 0.1, mM, 0.2, mM and 0.4, mM.
3. Pig FAPs cell adipogenesis induction
The above 5 trophic factors were added throughout the adipogenic differentiation (including MDI medium and INS medium), with 3 replicates per treatment setting.
When the fusion rate of the cells of the FAPs of the pigs is 85%, inoculating the cells to a 12-hole plate for culture, when the fusion rate of the cells is 85% -90%, replacing the cells with a lipid-forming induction culture medium MDI medium for inducing the FAPs to be lipid-forming and differentiating for 4 days, replacing a differentiation culture medium INS medium, and continuously culturing for 2 days.
MDI media contains IBMX 500. Mu.M, insulin 10. Mu.g/mL, rosiglitazone 2. Mu.g/mL and dexamethasone 1. Mu.M; INS medium contained 10. Mu.g/mL insulin.
4. Observation of the condition of differentiated polyester of FAPs in pigs
After the induction differentiation of the swine FAPs cells was completed, the medium was discarded, washed 2 times with 0.5mL of PBS, then fixed with 0.5mL of 4% paraformaldehyde for 15 min, then 4% paraformaldehyde was discarded, and washed 2 times with 0.5mL of PBS.
Lipid droplet size was observed in the microscope for each treatment group and compared by photographing.
The result shows that the addition of 100 mu M PC significantly promotes the differentiation of the FAPs cells of the pigs into polyester, and the fat drop becomes large; the addition of 0.2 mM Bet also has the effect of promoting the differentiation of swine FAPs cells into polyester, but has an effect less obvious than that of 100 mu M PC; the other 3 trophic factors had no effect on the cellular differentiation of porcine FAPs to polyester (fig. 1).
Example 2 validation and evaluation of the effects of trophic factors in 2D culture systems
1. Nile red (Nile red) dyeing
When the fusion rate of the cells of the FAPs of the pigs is 85%, inoculating the cells to a 12-hole plate for culture, when the fusion rate of the cells is 85% -90%, replacing the cells with a lipid-forming induction culture medium MDI medium for inducing the FAPs to be lipid-forming and differentiating for 4 days, replacing a differentiation culture medium INS medium, and continuously culturing for 2 days. The whole process of adipogenic differentiation was added with 0. Mu.M and 100. Mu.M PC, respectively.
After the induction differentiation of the swine FAPs cells was completed, the medium was discarded, washed 2 times with 0.5mL of PBS, then fixed with 0.5mL of 4% paraformaldehyde for 15 min, then 4% paraformaldehyde was discarded, and washed 2 times with 0.5mL of PBS. The samples were taken with PBS at 1:2000 dilute nile red fluorescent dye, add 300 μl of dye per well, incubate for 15 min in dark, discard dye, wash 3 times with PBS for 5 min each; the samples were taken with PBS at 1: DAPI dye (labeled nuclei) was diluted 5000, 300. Mu.L of dye was added to each well, incubated for 5 min in the dark, the dye was discarded, washed 3 times with PBS, followed by 50% glycerol sealed plate, and observed under a fluorescent microscope, photographed.
The results showed that 100. Mu.M PC group had more lipid droplets, suggesting that the addition of 100. Mu.M PC promoted the cellular differentiation of porcine FAPs to polyester (FIG. 2).
2. Gene expression detection related to fatty acid synthesis
To further explore how 100. Mu.M PC promotes the differentiation of swine FAPs cells into polyester, we examined the expression of genes involved in fat/fatty acid synthesis. When the fusion rate of the pig FAPs cells is 85%, inoculating the pig FAPs cells to a 12-hole plate for culture, collecting the pig FAPs cells after the adipogenic differentiation is finished, adding 0.5mL TRIzol reagent into each hole after PBS washing for 2 times, extracting cell RNA, and detecting the quality and concentration of the RNA by using a NanoDrop 2000 instrument. cDNA was synthesized using a reverse transcription kit (Thermo Fisher). Real-time quantitative PCR was performed using a Applied Biosystems StepOnePlusTM real-time PCR system and SYBR Green Master Mix (Roche, indianapolis, in, united States). The relative expression level of the gene was calculated by the 2- ΔΔct method.
The real-time fluorescent quantitative PCR results showed that 100. Mu.M PC significantly increased the expression of Pparg, plin1, fabp4, adipoq and Cidec (FIG. 3).
The primer sequences were as follows:
18S-F(SEQ ID NO.1):CCCACGGAATCGAGAAAGAG
18S-R(SEQ ID NO.2):TTGACGGAAGGGCACCA
Pparγ-F(SEQ ID NO.3):GGCGAGGGCGATCTTGACAG
Pparγ-R(SEQ ID NO.4):GATGCGAATGGCCACCTCTTT
Perilipin1-F(SEQ ID NO.5):CCCCCTGGTGGCGTCTGTAT
Perilipin1-R(SEQ ID NO.6):ACTGGAGGGCCGGTATCTTTTCT
Fabp4-F(SEQ ID NO.7):TGGAAACTTGTCTCCAGTG
Fabp4-R(SEQ ID NO.8):GGTACTTTCTGATCTAATGGTG
Adipoq-F(SEQ ID NO.9):CTCCTTCCACGTCACGGTCT
Adipoq-R(SEQ ID NO.10):CCAGATAGAGGAGCACAGAGCC
Leptin-F(SEQ ID NO.11):GGCCCTATCTGTCCTACGTTGAAG
Leptin-R(SEQ ID NO.12):TGGAAGGCAGACTGGTGAGGAT
Cidea-F(SEQ ID NO.13):TTATCGCCAGCAGAGTGGTC
Cidea-R(SEQ ID NO.14):GATGTAGGTACCAGCCGGTGT
Cidec-F(SEQ ID NO.15):ACAGAGAAACATGGAGCCCAA
Cidec-R(SEQ ID NO.16):GTCAGCGGTGCTTACTTTGC。
3. fat/fatty acid synthesis-related protein expression assay
Collecting pig FAPs cells after lipid differentiation, washing with PBS for 2 times, adding protease inhibitor-containing protein lysis buffer, homogenizing or ultrasonic crushing, centrifuging at 12000 rpm for 10min on ice for 30 min at 4deg.C, and transferring the supernatant to a new 1.5 mL EP tube. After the BCA method was used to determine the protein concentration, 5X sample buffer was added and the mixture was boiled at 100 ℃ for 10min to denature the protein. 10% polyacrylamide gel is prepared, protein electrophoresis is carried out, 90V is carried out for 30 min, and 130V is carried out for 1 h. The protein bands were analyzed by gel imaging analysis system through the procedures of membrane transfer, 1h of blocking, overnight incubation with primary antibody, TBST elution, incubation with secondary antibody at room temperature, and the like.
Western blot detection results show that 100 mu M PC significantly improves PLIN1 and FABP4 protein expression compared with a control group (FIG. 4).
Example 3 application to meat development in 3D culture or cell culture
1. Preparation of sodium alginate/gelatin 3D gel ball
Sodium alginate-gelatin solution (sodium alginate/gelatin mixed sol) with concentration of 2% was obtained by dissolving 0.5 g sodium alginate and 0.5 g gelatin in 50mL distilled water. 1g of calcium chloride was dissolved in 50mL distilled water to obtain a calcium chloride solution having a concentration of 2%. Heating sodium alginate-gelatin solution and calcium chloride solution at 98deg.C for 3 h respectively, sterilizing by ultraviolet irradiation of 3 h, and filtering with 0.22 μm filter membrane to ensure sterility.
2. Inoculating FAPs cells on sodium alginate and sodium alginate/gelatin 3D bracket
Pig FAPs cells at 37℃and 5% CO 2 Cell suspension was obtained by trypsin digestion and centrifugation when cultured in an incubator until cell confluence reached about 80%. 2mL of sterile chlorination was added to each well of a 12-well cell culture plateCalcium solution, cell suspension (1.5X10) 5 cell/ml) and sodium alginate/gelatin mixed sol according to the volume ratio of 1:2, uniformly mixing, dropwise adding the mixture into a calcium chloride solution by using a 1 mL pipette, and crosslinking for 10 minutes to form gel balls. Discard the remaining calcium chloride solution, wash twice with PBS, supplement growth medium (DMEM medium with 15% FBS), at 37℃with 5% CO 2 Culturing in an incubator for 48 hours. Then, the culture was carried out for 8 days and 6 days with MDI medium and INS medium (100. Mu.M PC in both media), respectively, and adipogenic differentiation culture was carried out. The adipogenic induction, the harvest and the nile red staining of the cells of the pig FAPs are consistent with those of the cells of the pig FAPs in 2D culture.
The nile red staining results showed: the addition of 100. Mu.M PC significantly more lipid droplets compared to the control without PC indicated that the addition of 100. Mu.M PC promoted the cell differentiation polyester of swine FAPs and increased the production efficiency of cell culture meat (FIG. 5).
The above embodiments are only illustrative of the preferred embodiments of the present invention and are not intended to limit the scope of the present invention, and various modifications and improvements made by those skilled in the art to the technical solutions of the present invention should fall within the protection scope defined by the claims of the present invention without departing from the design spirit of the present invention.
Claims (8)
1. The application of phosphatidylcholine in preparing a preparation for promoting the cell differentiation polyester of the pig FAPs.
2. The use according to claim 1, wherein phosphatidylcholine alone is the active ingredient in the formulation.
3. The use according to claim 2, wherein the formulation further comprises excipients.
4. A method for preparing cell culture meat, comprising the steps of:
(1) Preparation of sodium alginate/gelatin 3D gel ball
Dissolving 0.5 g sodium alginate and 0.5 g gelatin in 50mL of distilled water to obtain sodium alginate/gelatin mixed sol with the concentration of 2%, dissolving 1g of calcium chloride in 50mL distilled water to obtain calcium chloride solution with the concentration of 2%, dropwise adding the sodium alginate/gelatin mixed sol into the calcium chloride solution, and crosslinking for 5-15 min to obtain sodium alginate/gelatin 3D gel spheres;
(2) Inoculating FAPs cells on sodium alginate and sodium alginate/gelatin 3D bracket
Adding a calcium chloride solution into a cell culture plate, and mixing a pig FAPs cell suspension with sodium alginate/gelatin mixed sol according to a volume ratio of 1: 1-3, dropwise adding the mixture into a calcium chloride solution, and crosslinking for 5-15 min to form gel balls; discarding the residual calcium chloride solution, supplementing the growth medium, and adding 5% CO at 37deg.C 2 Culturing in environment, performing adipogenic differentiation culture, and adding 1-100 μm phosphatidylcholine during the adipogenic differentiation culture to obtain cell culture meat.
5. The method according to claim 4, wherein the step (1) further comprises heating the sodium alginate solution-gelatin solution and the calcium chloride solution at 98℃for 3 h, respectively, sterilizing the solution by ultraviolet irradiation for 3 h, and filtering the calcium chloride solution through a 0.22 μm filter.
6. The method of claim 5, wherein the cells of swine FAPs in step (2) are at 37℃and 5% CO 2 Culturing in an incubator until the cell confluence rate reaches 75-85%, and obtaining the cell suspension of the pig FAPs through trypsin digestion and centrifugation.
7. The method of claim 6, wherein the concentration of the cell suspension of swine FAPs in step (2) is 1.5X10 5 cell/ml。
8. The method according to claim 7, wherein the crosslinking time in the step (2) is 10min.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310530141.3A CN116590225B (en) | 2023-05-12 | 2023-05-12 | Application of phosphatidylcholine in preparation of preparation for promoting pig FAPs cell differentiation polyester |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310530141.3A CN116590225B (en) | 2023-05-12 | 2023-05-12 | Application of phosphatidylcholine in preparation of preparation for promoting pig FAPs cell differentiation polyester |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116590225A CN116590225A (en) | 2023-08-15 |
CN116590225B true CN116590225B (en) | 2023-10-20 |
Family
ID=87603897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310530141.3A Active CN116590225B (en) | 2023-05-12 | 2023-05-12 | Application of phosphatidylcholine in preparation of preparation for promoting pig FAPs cell differentiation polyester |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116590225B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113355281A (en) * | 2021-06-19 | 2021-09-07 | 浙江大学 | Method for efficiently separating mouse intramuscular fiber-adipogenic progenitor cells |
CN114173806A (en) * | 2019-07-26 | 2022-03-11 | 密歇根州立大学董事会 | Method for preventing or treating skeletal muscle steatosis |
CN115029305A (en) * | 2022-06-17 | 2022-09-09 | 浙江大学 | Separation and identification method for pig FAPs (FAPs) cells and application of FAPs cells |
WO2023003471A1 (en) * | 2021-07-22 | 2023-01-26 | Mosa Meat B.V. | Method for producing cultured fat for animal consumption. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110212523A1 (en) * | 2008-11-11 | 2011-09-01 | Yukio Kato | Differentiation-inducing culture medium additive and use thereof |
-
2023
- 2023-05-12 CN CN202310530141.3A patent/CN116590225B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114173806A (en) * | 2019-07-26 | 2022-03-11 | 密歇根州立大学董事会 | Method for preventing or treating skeletal muscle steatosis |
CN113355281A (en) * | 2021-06-19 | 2021-09-07 | 浙江大学 | Method for efficiently separating mouse intramuscular fiber-adipogenic progenitor cells |
WO2023003471A1 (en) * | 2021-07-22 | 2023-01-26 | Mosa Meat B.V. | Method for producing cultured fat for animal consumption. |
CN115029305A (en) * | 2022-06-17 | 2022-09-09 | 浙江大学 | Separation and identification method for pig FAPs (FAPs) cells and application of FAPs cells |
Non-Patent Citations (3)
Title |
---|
Jiaqi Liu et al.."CRTC3 Regulates the Lipid Metabolism and Adipogenic Differentiation of Porcine Intramuscular and Subcutaneous Adipocytes by Activating the Calcium Pathway".《J. Agric. Food Chem.》.2021,第69卷第7243-7255页. * |
Ziye Xu et al.."Single‐cell RNA sequencing and lipidomics reveal cell and lipid dynamics of fat infiltration in skeletal muscle".《Journal of Cachexia, Sarcopenia and Muscle》.2021,第12卷第109-129页. * |
唐海鸿 等."基于FibroScan 技术评价疏肝消脂方加减治疗 非酒精性脂肪性肝病的临床疗效".《中医杂志》.2018,第59卷(第7期),第594-598页. * |
Also Published As
Publication number | Publication date |
---|---|
CN116590225A (en) | 2023-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106754668B (en) | Stem cell culture solution and injection | |
US11339372B2 (en) | Serum-free medium inducing differentiation of umbilical cord mesenchymal stem cell into insulin-secretion-like cell and preparation method and use thereof | |
CN103509729B (en) | A kind of produce the construction method of coenzyme Q10 engineering bacteria, engineering bacteria and application thereof | |
CN107937342B (en) | Method for amplifying neural stem cells through endothelial cell-derived exosomes | |
CN101818127B (en) | Method for separating and culturing mouse primitive spermatogonia | |
CN110564682B (en) | Method for large-scale production of human adipose-derived mesenchymal stem cell exosomes | |
CN103930542A (en) | Brown fat cell compositions and methods | |
CN105462884B (en) | The isolation and purification method of mycoplasma anatis culture medium and mycoplasma anatis | |
CN110747163B (en) | Method for improving adipogenic differentiation of human adipose-derived mesenchymal stem cells and special culture medium thereof | |
CN116574172B (en) | Recombinant humanized type I collagen and preparation method thereof | |
CN106591224B (en) | Method for separating and purifying high-purity chicken precursor intramuscular fat cells and constructing coculture system of high-purity chicken precursor intramuscular fat cells and muscle satellite cells | |
CN105441371B (en) | A kind of genetic engineering bacterium and its application in production Co-Q10 | |
CN113088487B (en) | Mesenchymal stem cell adipogenic transformation inhibitor | |
CN106148455A (en) | A kind of derivant and application thereof | |
CN108251378A (en) | A kind of interstital stem cell excretion body for being overexpressed PTGDS genes and its preparation method and application | |
AU2020103625A4 (en) | Applications of bacillus calmette-guerin (bcg) polysaccharide and nucleic acid in in-vitro culture of cytokine-induced-killer (cik) cells and preparation of antitumor drugs | |
CN116590225B (en) | Application of phosphatidylcholine in preparation of preparation for promoting pig FAPs cell differentiation polyester | |
CN111925943B (en) | Chlorella vulgaris, and its culture method and application | |
CN116790506A (en) | Cynoglossus semilaevis gonad cell engineering exosome and preparation method and application thereof | |
CN114703120B (en) | Separation method of animal nervous system vascular smooth muscle cell single cells | |
CN113801843B (en) | Method for enhancing human urine-derived stem cell stem property | |
CN102703380A (en) | Sub-totipotent stem cell, preparation method and application thereof | |
CN113106059A (en) | High-migration mesenchymal stem cell and preparation method and application thereof | |
CN113322226A (en) | Exosome derived from three-dimensional cultured embryonic stem cells and application of exosome in preparation of medicine for treating hepatic fibrosis | |
CN106434546B (en) | Method for preparing mesenchymal stem cells by fully utilizing umbilical cord resources |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |